Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
444912-75-2
|
| gptkbp:criteria |
gptkb:CB2_receptor
|
| gptkbp:discoveredBy |
Alexandros Makriyannis
|
| gptkbp:drugClass |
analgesic
anti-allodynic anti-hyperalgesic |
| gptkbp:hasInChIKey |
gptkb:QJQJQJQJQJQJQJ-UHFFFAOYSA-N
|
| gptkbp:hasMolecularFormula |
C20H28BrN3O2
|
| gptkbp:hasSMILES |
CC(C)[C@H](NC(=O)c1cn(c2c1cccc2)CCCCBr)C(=O)N
|
| gptkbp:heldBy |
cannabinoid receptor agonist
|
| https://www.w3.org/2000/01/rdf-schema#label |
AM-1241
|
| gptkbp:IUPACName |
(R)-N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-bromopentyl)-1H-indole-3-carboxamide
|
| gptkbp:legalStatus |
gptkb:Schedule_I_(United_States)
|
| gptkbp:meltingPoint |
unknown
|
| gptkbp:molecularWeight |
422.36 g/mol
|
| gptkbp:PubChem_CID |
10405522
8583322 |
| gptkbp:studiedBy |
pain management
peripheral neuropathy cannabinoid receptor studies |
| gptkbp:bfsParent |
gptkb:CB2_receptor
|
| gptkbp:bfsLayer |
7
|